Maher AlQuaimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maher AlQuaimi has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Abdulelah Mastour Aldhahir
Respiratory Therapy Program, Department of Nursing, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia
2 shared publications - Hana Alsomali
Department of Respiratory Care, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
2 shared publications - Saeed Mardy Alghamdi
Respiratory Care Program, Clinical Technology Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
2 shared publications Abdullah A. Almojaibel
1 shared publicationAbdullah Almojaibel
1 shared publication- Ahmed H. Alasimi
National Heart and Lung Institute, Imperial College London, London, UK
1 shared publication
Latest Publications
- 9 October 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 263
Barriers to early rehabilitation and mobilization in adult ICUs: A multicenter survey in the Eastern region of Saudi Arabia
- 9 October 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 263
Barriers to early rehabilitation and mobilization in adult ICUs: A multicenter survey in the Eastern region of Saudi Arabia
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-11
Barriers Facing the Hospitals from Establishing Pulmonary Rehabilitation Programs in the Usual Care of COPD and Respiratory Patients in Saudi Arabia
The prevalence of pulmonary diseases, including chronic obstructive pulmonary diseases, in Saudi Arabia is high, and pulmonary rehabilitation is not available in most Saudi hospitals. The causes that prevent hospitals in Saudi Arabia are still unclear and need more investigation. Thus, the aim of this study is to determine why pulmonary rehabilitation is not part of the usual COPD and respiratory disease management in Saudi Arabia. A cross-sectional study was conducted in Saudi Arabia with two questionnaires: the first for the healthcare providers and the second for pulmonary patients. About 349 healthcare providers completed the first questionnaire. The three highest barriers for establishing pulmonary rehabilitation in Saudi Arabia were shortage of healthcare providers (n = 183), followed by reduction of funds (n = 146) and lack of hospital room and capacity, respectively (n = 101 and n = 78). From the healthcare provider’s point of view, the two highest barriers to preventing patients from attending pulmonary rehabilitation were transportation (n = 151), followed by lack of perceived benefits (n = 142). Almost half of healthcare providers (44%) intended to implement percentage a pulmonary rehabilitation program in Saudi Arabia. About 269 pulmonary patients filled out the second questionnaire. The three highest barriers from the patients’ point of view to attend the pulmonary rehabilitation were being consistent with the program, lack of transportation, and wasting time in the program. The main barriers that prevent the implementation of a pulmonary rehabilitation program were lack of healthcare professionals and funds and low hospital capacity. The most barriers that prevent pulmonary patients from attending pulmonary rehabilitation programs were transportation challenges and lack of perceived benefits. About half of the healthcare providers intended to implement a pulmonary rehabilitation program in Saudi Arabia.
- 1 April 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-11
Open AccessBarriers Facing the Hospitals from Establishing Pulmonary Rehabilitation Programs in the Usual Care of COPD and Respiratory Patients in Saudi Arabia
The prevalence of pulmonary diseases, including chronic obstructive pulmonary diseases, in Saudi Arabia is high, and pulmonary rehabilitation is not available in most Saudi hospitals. The causes that prevent hospitals in Saudi Arabia are still unclear and need more investigation. Thus, the aim of this study is to determine why pulmonary rehabilitation is not part of the usual COPD and respiratory disease management in Saudi Arabia. A cross-sectional study was conducted in Saudi Arabia with two questionnaires: the first for the healthcare providers and the second for pulmonary patients. About 349 healthcare providers completed the first questionnaire. The three highest barriers for establishing pulmonary rehabilitation in Saudi Arabia were shortage of healthcare providers (n = 183), followed by reduction of funds (n = 146) and lack of hospital room and capacity, respectively (n = 101 and n = 78). From the healthcare provider’s point of view, the two highest barriers to preventing patients from attending pulmonary rehabilitation were transportation (n = 151), followed by lack of perceived benefits (n = 142). Almost half of healthcare providers (44%) intended to implement percentage a pulmonary rehabilitation program in Saudi Arabia. About 269 pulmonary patients filled out the second questionnaire. The three highest barriers from the patients’ point of view to attend the pulmonary rehabilitation were being consistent with the program, lack of transportation, and wasting time in the program. The main barriers that prevent the implementation of a pulmonary rehabilitation program were lack of healthcare professionals and funds and low hospital capacity. The most barriers that prevent pulmonary patients from attending pulmonary rehabilitation programs were transportation challenges and lack of perceived benefits. About half of the healthcare providers intended to implement a pulmonary rehabilitation program in Saudi Arabia.
- Open Access
- 9 November 2025
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 22 (6) , em700
Effects of inspiratory muscle training on functional fitness in obese and overweight adults: A systematic review of randomised control trials
Background: Obesity is a chronic metabolic disorder that affects the cardiopulmonary system. Its management, mainly, focuses on weight loss programmes without incorporating respiratory management. Threshold inspiratory muscle trainers (IMT) was used to strengthen inspiratory muscles and improve functional exercise capacity in obese and overweight individuals. Objective: To investigate the effectiveness of IMT on functional fitness in overweight and obese individuals. Methods: An electronic search was conducted in Scopus, PubMed, Web of Science, Dimension, Medline, and Open Alex database. The review included studies of randomised controlled trials (RCTs), which were conducted for the last 20 years on healthy adults with obesity, and the studies investigating the effects of IMT on multiple parameters. The revised Cochrane risk of bias tool (RoB 2.0) was employed to assess the methodological quality of the included studies. Results: The initial search yielded 832 studies. Ultimately, five randomised control trials with three to four measurement outcomes were included. Inspiratory muscle strength and functional capacity outcomes were measured, with pre- and post-IMT intervention assessments performed. Results suggest that IMT improves functional capacity (6MWT) and inspiratory muscle strength without a significant difference in the pulmonary function test. Conclusion: IMT improves inspiratory muscle strength and functional capacity in obese and overweight adult individuals. Healthcare professionals should consider including IMT to any prescribed rehabilitation program particularly for those with obese and overweight.
- 9 November 2025
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 22 (6) , em700
Open AccessEffects of inspiratory muscle training on functional fitness in obese and overweight adults: A systematic review of randomised control trials
Background: Obesity is a chronic metabolic disorder that affects the cardiopulmonary system. Its management, mainly, focuses on weight loss programmes without incorporating respiratory management. Threshold inspiratory muscle trainers (IMT) was used to strengthen inspiratory muscles and improve functional exercise capacity in obese and overweight individuals. Objective: To investigate the effectiveness of IMT on functional fitness in overweight and obese individuals. Methods: An electronic search was conducted in Scopus, PubMed, Web of Science, Dimension, Medline, and Open Alex database. The review included studies of randomised controlled trials (RCTs), which were conducted for the last 20 years on healthy adults with obesity, and the studies investigating the effects of IMT on multiple parameters. The revised Cochrane risk of bias tool (RoB 2.0) was employed to assess the methodological quality of the included studies. Results: The initial search yielded 832 studies. Ultimately, five randomised control trials with three to four measurement outcomes were included. Inspiratory muscle strength and functional capacity outcomes were measured, with pre- and post-IMT intervention assessments performed. Results suggest that IMT improves functional capacity (6MWT) and inspiratory muscle strength without a significant difference in the pulmonary function test. Conclusion: IMT improves inspiratory muscle strength and functional capacity in obese and overweight adult individuals. Healthcare professionals should consider including IMT to any prescribed rehabilitation program particularly for those with obese and overweight.
- Open Access
- 1 November 2020
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 13, 1635-1648
Global Current Practices of Ventilatory Support Management in COVID-19 Patients: An International Survey
Background: As the global outbreak of COVID-19 continues to ravage the world, it is important to understand how frontline clinicians manage ventilatory support and the various limiting factors. Methods: An online survey composed of 32 questions was developed and validated by an international expert panel. Results: Overall, 502 respondents from 40 countries across six continents completed the survey. The mean number (±SD) of ICU beds was 64 ± 84. The most popular initial diagnostic tools used for treatment initiation were arterial blood gas (48%) and clinical presentation (37.5%), while the national COVID-19 guidelines were the most used (61.2%). High flow nasal cannula (HFNC) (53.8%), non-invasive ventilation (NIV) (47%), and invasive mechanical ventilation (IMV) (92%) were mostly used for mild, moderate, and severe COVID-19 cases, respectively. However, only 38.8%, 56.6% and 82.9% of the respondents had standard protocols for HFNC, NIV, and IMV, respectively. The most frequently used modes of IMV and NIV were volume control (VC) (36.1%) and continuous positive airway pressure/pressure support (CPAP/PS) (40.6%). About 54% of the respondents did not adhere to the recommended, regular ventilator check interval. The majority of the respondents (85.7%) used proning with IMV, with 48.4% using it for 12– 16 hours, and 46.2% had tried awake proning in combination with HFNC or NIV. Increased staff workload (45.02%), lack of trained staff (44.22%) and shortage of personal protective equipment (PPE) (42.63%) were the main barriers to COVID-19 management. Conclusion: Our results show that general clinical practices involving ventilatory support were highly heterogeneous, with limited use of standard protocols and most frontline clinicians depending on isolated and varied management guidelines. We found increased staff workload, lack of trained staff and shortage of PPE to be the main limiting factors affecting global COVID-19 ventilatory support management.
- 1 November 2020
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 13, 1635-1648
Open AccessGlobal Current Practices of Ventilatory Support Management in COVID-19 Patients: An International Survey
Background: As the global outbreak of COVID-19 continues to ravage the world, it is important to understand how frontline clinicians manage ventilatory support and the various limiting factors. Methods: An online survey composed of 32 questions was developed and validated by an international expert panel. Results: Overall, 502 respondents from 40 countries across six continents completed the survey. The mean number (±SD) of ICU beds was 64 ± 84. The most popular initial diagnostic tools used for treatment initiation were arterial blood gas (48%) and clinical presentation (37.5%), while the national COVID-19 guidelines were the most used (61.2%). High flow nasal cannula (HFNC) (53.8%), non-invasive ventilation (NIV) (47%), and invasive mechanical ventilation (IMV) (92%) were mostly used for mild, moderate, and severe COVID-19 cases, respectively. However, only 38.8%, 56.6% and 82.9% of the respondents had standard protocols for HFNC, NIV, and IMV, respectively. The most frequently used modes of IMV and NIV were volume control (VC) (36.1%) and continuous positive airway pressure/pressure support (CPAP/PS) (40.6%). About 54% of the respondents did not adhere to the recommended, regular ventilator check interval. The majority of the respondents (85.7%) used proning with IMV, with 48.4% using it for 12– 16 hours, and 46.2% had tried awake proning in combination with HFNC or NIV. Increased staff workload (45.02%), lack of trained staff (44.22%) and shortage of personal protective equipment (PPE) (42.63%) were the main barriers to COVID-19 management. Conclusion: Our results show that general clinical practices involving ventilatory support were highly heterogeneous, with limited use of standard protocols and most frontline clinicians depending on isolated and varied management guidelines. We found increased staff workload, lack of trained staff and shortage of PPE to be the main limiting factors affecting global COVID-19 ventilatory support management.
- Open Access
- 8 May 2017
- Published by Springer Nature
Trial of lung rehabilitation customised for interstitial lung disease
- 8 May 2017
- Published by Springer Nature
Open AccessTrial of lung rehabilitation customised for interstitial lung disease
- 23 February 2016
- Published by SAGE Publications in Respiratory Care
- Vol. 61 (5) , 600-606
Quantifying Aerosol Delivery in Simulated Spontaneously Breathing Patients With Tracheostomy Using Different Humidification Systems With or Without Exhaled Humidity
BACKGROUND: Aerosol and humidification therapy are used in long-term airway management of critically ill patients with a tracheostomy. The purpose of this study was to determine delivery efficiency of jet and mesh nebulizers combined with different humidification systems in a model of a spontaneously breathing tracheotomized adult with or without exhaled heated humidity. METHODS: An in vitro model was constructed to simulate a spontaneously breathing adult (tidal volume, 400 mL; breathing frequency, 20 breaths/min; inspiratory-expiratory ratio, 1:2) with a tracheostomy using a teaching manikin attached to a test lung through a collecting filter (Vital Signs Respirgard II). Exhaled heat and humidity were simulated using a cascade humidifier set to deliver 37°C and >95% relative humidity. Albuterol sulfate (2.5 mg/3 mL) was administered with a jet nebulizer (AirLife Misty Max) operated at 10 L/min and a mesh nebulizer (Aeroneb Solo) using a heated pass-over humidifier, unheated large volume humidifier both at 40 L/min output and heat-and-moisture exchanger. Inhaled drug eluted from the filter was analyzed via spectrophotometry (276 nm). RESULTS: Delivery efficiency of the jet nebulizer was less than that of the mesh nebulizer under all conditions ( P < .05). Aerosol delivery with each nebulizer was greatest on room air and lowest when heated humidifiers with higher flows were used. Exhaled humidity decreased drug delivery up to 44%. CONCLUSIONS: The jet nebulizer was less efficient than the mesh nebulizer in all conditions tested in this study. Aerosol deposition with each nebulizer was lowest with the heated humidifier with high flow. Exhaled humidity reduced inhaled dose of drug compared with a standard model with nonheated/nonhumidified exhalation. Further clinical research is warranted to understand the impact of exhaled humidity on aerosol drug delivery in spontaneously breathing patients with tracheostomy using different types of humidifiers.
- 23 February 2016
- Published by SAGE Publications in Respiratory Care
- Vol. 61 (5) , 600-606
Quantifying Aerosol Delivery in Simulated Spontaneously Breathing Patients With Tracheostomy Using Different Humidification Systems With or Without Exhaled Humidity
BACKGROUND: Aerosol and humidification therapy are used in long-term airway management of critically ill patients with a tracheostomy. The purpose of this study was to determine delivery efficiency of jet and mesh nebulizers combined with different humidification systems in a model of a spontaneously breathing tracheotomized adult with or without exhaled heated humidity. METHODS: An in vitro model was constructed to simulate a spontaneously breathing adult (tidal volume, 400 mL; breathing frequency, 20 breaths/min; inspiratory-expiratory ratio, 1:2) with a tracheostomy using a teaching manikin attached to a test lung through a collecting filter (Vital Signs Respirgard II). Exhaled heat and humidity were simulated using a cascade humidifier set to deliver 37°C and >95% relative humidity. Albuterol sulfate (2.5 mg/3 mL) was administered with a jet nebulizer (AirLife Misty Max) operated at 10 L/min and a mesh nebulizer (Aeroneb Solo) using a heated pass-over humidifier, unheated large volume humidifier both at 40 L/min output and heat-and-moisture exchanger. Inhaled drug eluted from the filter was analyzed via spectrophotometry (276 nm). RESULTS: Delivery efficiency of the jet nebulizer was less than that of the mesh nebulizer under all conditions ( P < .05). Aerosol delivery with each nebulizer was greatest on room air and lowest when heated humidifiers with higher flows were used. Exhaled humidity decreased drug delivery up to 44%. CONCLUSIONS: The jet nebulizer was less efficient than the mesh nebulizer in all conditions tested in this study. Aerosol deposition with each nebulizer was lowest with the heated humidifier with high flow. Exhaled humidity reduced inhaled dose of drug compared with a standard model with nonheated/nonhumidified exhalation. Further clinical research is warranted to understand the impact of exhaled humidity on aerosol drug delivery in spontaneously breathing patients with tracheostomy using different types of humidifiers.